Diaceutics PLC (DXRX.L) has a MoatMap StockRank of 62/100 based on Quality (60/100), Value (24/100), and Momentum (64/100) factor scores. The current signal is HOLD. Diaceutics operates a high-margin, asset-light data platform that acts as a critical gatekeeper for precision medicine diagnostics. As pharma increasingly relies on targeted therapies, Diaceutics' network effects and proprietary data library create a strong competitive moat, matching the Terry Smith quality filter.
Diaceutics PLC provides data analytics and implementation services to global pharmaceutical companies to optimize diagnostic testing for precision medicine. Powered by its proprietary DXRX platform, the company integrates global lab data to identify and resolve gaps in patient testing pathways. It is a niche healthcare technology leader operating at the intersection of diagnostics and precision therapeutics.
| Price | $1.91 |
| Market Cap | $162M |
| P/E (Forward) | 35.26 |
| Price/Book | 3.00 |
| Return on Equity | 0.2% |
| Return on Invested Capital | -4.5% |
| Debt/Equity | 2.85 |
| Gross Margin | 81.9% |
| Operating Margin | 13.5% |
| Revenue Growth | 20.3% |
| Free Cash Flow | $-8M |
Diaceutics PLC operates in the Health Information Services industry, part of the Healthcare sector (United Kingdom).